NeurAxis, Inc. logo

NRXSNeurAxis, Inc.

NRXS Stock Price, Valuation & Chart | NeurAxis, Inc.

Compare

NRXS Historical price chart

NRXS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization74.24M
PE Ratio-7.35
EPS-0.81
Trading Volume79.52K
Today's High/Low6.04/5.82
Dividend Yield0.00
52 Week High/Low9.33/2.21
Shares Outstanding12.48M
NRXS Financial Statement
NRXS Analyst ratings
NRXS Analysis & performance metrics

NRXS Company profile

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended…

NRXS Management team

Management
Timothy Robert HenrichsCFO
Chief Financial Officer
Adrian Miranda
Senior Vice President of Science & Technology and Chief Medical Officer
Thomas Carrico
Chief Regulatory Officer and Compliance & Privacy Officer
Brian CarricoCEO
President, Chief Executive Officer & Director
Christopher Robin Brown D.D.S.CTO
Founder, Director of Innovation & Director
Total 5 executives

NRXS Frequently asked questions

What is NeurAxis, Inc. (NRXS) Stock Price?

Current stock price of NeurAxis, Inc. (NRXS) stock is $5.950. The stock price is +2.41% higher in the session. The intraday range can be seen from this page. Volume of NeurAxis, Inc. (NRXS) stock is 79.52K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the NeurAxis, Inc. (NRXS) stock price going up or down today?

The stock price of NeurAxis, Inc. (NRXS) can change with earnings, company news, and overall market sentiment. NeurAxis, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NeurAxis, Inc. stock expensive at its current price?

Whether NeurAxis, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NRXS on this page is -7.35. EPS on this page is -0.81. Compare those figures with peers and growth expectations before deciding if the current NeurAxis, Inc. price is justified.

How has the stock price of NeurAxis, Inc. (NRXS) performed historically?

Historical performance for NeurAxis, Inc. (NRXS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NRXS reacted to past earnings and market events.

Should I buy NeurAxis, Inc. (NRXS) stock, at this price?

Buying NeurAxis, Inc. (NRXS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.